Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psychedelic drug
Biotech
Definium’s LSD depression drug produces ‘best ever’ ph. 3 data
The biotech’s LSD recipe, DT120 ODT, scored wins on all primary and key secondary endpoints of the 149-patient Emerge trial.
Darren Incorvaia
Jun 22, 2026 7:00am
‘Real momentum’ or ‘absurd’? Trump stance shakes up psychedelics
May 4, 2026 3:30am
Compass, Usona and Transcend score priority vouchers amid psychedelic push
Apr 24, 2026 3:51pm
Trump orders FDA to fast-track reviews of psychedelic drugs
Apr 20, 2026 5:30am
AtaiBeckley's MDMA drug improves anxiety in ph. 2 trial
Feb 26, 2026 1:32pm
Compass guides psychedelic to 2nd pivotal depression win
Feb 17, 2026 8:39am
